Frédéric Barbey

1.9k total citations
44 papers, 1.1k citations indexed

About

Frédéric Barbey is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Frédéric Barbey has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 13 papers in Epidemiology and 11 papers in Rheumatology. Recurrent topics in Frédéric Barbey's work include Lysosomal Storage Disorders Research (29 papers), Trypanosoma species research and implications (11 papers) and Glycogen Storage Diseases and Myoclonus (9 papers). Frédéric Barbey is often cited by papers focused on Lysosomal Storage Disorders Research (29 papers), Trypanosoma species research and implications (11 papers) and Glycogen Storage Diseases and Myoclonus (9 papers). Frédéric Barbey collaborates with scholars based in Switzerland, France and Czechia. Frédéric Barbey's co-authors include Dominique Joly, Michel Daudon, Paul Jungers, Gabriel Choukroun, Olivier Lidove, Soumeya Bekri, Aleš Linhart, Raphael Schiffmann, Gere Sunder‐Plassmann and Michael Beck and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Frédéric Barbey

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Barbey Switzerland 16 671 321 231 226 215 44 1.1k
Renzo Mignani Italy 19 1.0k 1.5× 381 1.2× 59 0.3× 365 1.6× 270 1.3× 58 1.3k
Sima Canaan–Kühl Germany 15 398 0.6× 188 0.6× 74 0.3× 110 0.5× 110 0.5× 29 690
Saskia M. Rombach Netherlands 18 1.6k 2.3× 759 2.4× 72 0.3× 378 1.7× 499 2.3× 36 1.8k
Bojan Vujkovac Slovenia 15 602 0.9× 247 0.8× 23 0.1× 193 0.9× 144 0.7× 42 772
Esther Noël France 17 255 0.4× 113 0.4× 30 0.1× 293 1.3× 92 0.4× 50 807
Bernard Klionsky United States 12 251 0.4× 98 0.3× 75 0.3× 95 0.4× 79 0.4× 29 635
Boris Senior United States 21 395 0.6× 71 0.2× 83 0.4× 176 0.8× 59 0.3× 49 1.1k
Jana Reiterová Czechia 16 129 0.2× 43 0.1× 146 0.6× 84 0.4× 28 0.1× 53 663
Makio Kawakami Japan 16 88 0.1× 89 0.3× 122 0.5× 56 0.2× 25 0.1× 48 784
Debora Karetová Czechia 12 492 0.7× 325 1.0× 32 0.1× 140 0.6× 176 0.8× 41 696

Countries citing papers authored by Frédéric Barbey

Since Specialization
Citations

This map shows the geographic impact of Frédéric Barbey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Barbey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Barbey more than expected).

Fields of papers citing papers by Frédéric Barbey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Barbey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Barbey. The network helps show where Frédéric Barbey may publish in the future.

Co-authorship network of co-authors of Frédéric Barbey

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Barbey. A scholar is included among the top collaborators of Frédéric Barbey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Barbey. Frédéric Barbey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maurizi, Niccolò, Albina Nowak, Christiane Gruner, et al.. (2024). Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy. Heart. 110(15). 997–1004. 6 indexed citations
2.
Beitzke, Dietrich, Senta Graf, Max Lenz, et al.. (2023). Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease. Life. 13(5). 1213–1213. 10 indexed citations
3.
Tebani, Abdellah, Frédéric Barbey, Olivier Dormond, et al.. (2023). Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease. Translational research. 258. 47–59. 15 indexed citations
4.
Fontana, A., David Viertl, Gilles Allenbach, et al.. (2021). A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I. Molecular Genetics and Metabolism. 134(4). 287–300. 22 indexed citations
5.
Franzen, Daniel, Albina Nowak, Sarah R. Haile, et al.. (2017). Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study. PLoS ONE. 12(7). e0180437–e0180437. 10 indexed citations
6.
Lidove, Olivier, Frédéric Barbey, Dau‐Ming Niu, et al.. (2016). Fabry in the older patient: Clinical consequences and possibilities for treatment. Molecular Genetics and Metabolism. 118(4). 319–325. 13 indexed citations
7.
Lidove, Olivier, Frédéric Barbey, & Dominique Joly. (2016). Traitement de la maladie de Fabry : succès, échecs, espoirs. Néphrologie & Thérapeutique. 12. S105–S113. 1 indexed citations
8.
Tran, Christel, Frédéric Barbey, Luisa Bonafé, Nelly Pitteloud, & Ilse Kern. (2015). [b]Erreurs[/b] innées du métabolisme : transition enfant-adulte. Revue Médicale Suisse. 11(462). 445–449. 1 indexed citations
9.
Franzen, Daniel, et al.. (2013). Pulmonary involvement in Fabry disease: Overview and perspectives. European Journal of Internal Medicine. 24(8). 707–713. 24 indexed citations
10.
Golshayan, Déla, et al.. (2013). Phenytoin-associated severe hypocalcemia with seizures in a patient with aTSC2-PKD1contiguous gene syndrome. Renal Failure. 35(6). 866–868. 9 indexed citations
11.
Golshayan, Déla, et al.. (2012). MR imaging as a specific diagnostic tool for bilateral microcysts in chronic lithium nephropathy. Kidney International. 81(6). 601–601. 8 indexed citations
12.
Chévrier, Marc, Noureddine Brakch, Céline Lesueur, et al.. (2010). Autophagosome maturation is impaired in Fabry disease. Autophagy. 6(5). 589–599. 94 indexed citations
13.
Mehta, Atul, Michael Beck, Perry Elliott, et al.. (2009). Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. The Lancet. 374(9706). 1986–1996. 208 indexed citations
14.
Lidove, Olivier, Dominique Joly, Frédéric Barbey, et al.. (2007). Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature. International Journal of Clinical Practice. 61(2). 293–302. 47 indexed citations
15.
Bekri, Soumeya, Olivier Lidove, R. Jaussaud, Bertrand Knebelmann, & Frédéric Barbey. (2006). The Role of Ceramide Trihexoside (Globotriaosylceramide) in the Diagnosis and Follow-Up of the Efficacy of Treatment of Fabry Disease: A Review of the Literature. Cardiovascular & Hematological Agents in Medicinal Chemistry. 4(4). 289–297. 44 indexed citations
16.
Lidove, Olivier, Uma Ramaswami, R. Jaussaud, et al.. (2006). Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey. International Journal of Clinical Practice. 60(9). 1053–1059. 28 indexed citations
17.
Barbey, Frédéric, Noureddine Brakch, Aleš Linhart, et al.. (2006). Increased carotid intima–media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatrica. 95(S451). 63–68. 12 indexed citations
18.
Barbey, Frédéric. (2003). A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes. Nephrology Dialysis Transplantation. 18(10). 2193–2196. 11 indexed citations
19.
Barbey, Frédéric, et al.. (2001). L'infarctus rénal : un diagnostic méconnu : Néphrologie. 59(2336). 488–493. 2 indexed citations
20.
Barbey, Frédéric, Olivier Lidove, D Droz, & J P Grünfeld. (2000). Maladie de Fabry: aspects cliniques et perspectives thérapeutiques.. Schweizerische medizinische Wochenschrift. 130(21). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renzo Mignani Breakdown of academic impact, for papers by Sima Canaan–Kühl Breakdown of academic impact, for papers by Saskia M. Rombach Breakdown of academic impact, for papers by Bojan Vujkovac Breakdown of academic impact, for papers by Esther Noël Breakdown of academic impact, for papers by Bernard Klionsky Breakdown of academic impact, for papers by Boris Senior Breakdown of academic impact, for papers by Jana Reiterová Breakdown of academic impact, for papers by Makio Kawakami Breakdown of academic impact, for papers by Debora Karetová
Rankless by CCL
2026